Literature DB >> 12527892

p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.

Gila Lilling1, Novitsky Elena, Yechezkel Sidi, Mary Bakhanashvili.   

Abstract

The tumor suppressor protein p53 plays an important role in maintenance of the genomic integrity of cells. p53 possesses an intrinsic 3'-->5' exonuclease activity. p53 was found in the nucleus and in the cytoplasm of the cell. In order to evaluate the subcellular location and extent of p53-associated 3'--> 5' exonuclease activity, we established an in vitro experimental system of cell lines with different nuclear/cytoplasmic distribution of p53. Nuclear and cytoplasmic extracts obtained from LCC2 cells (expressing a high level of cytoplasmic wild-type p53), MCF-7 cells (expressing a high level of wild-type nuclear p53), MDA cells (expressing mutant p53) and H1299 cells (p53-null) were subjected to the analysis of exonuclease activity. Interestingly, 3'-->5' exonuclease was predominantly cytoplasmic; the nuclear extracts derived from all cell lines tested, exerted a low level of exonuclease activity. Cytoplasmic extracts of LCC2 cells, with a high level of wild-type p53, showed an enhanced exonuclease activity in comparison to those expressing either a low level of wild-type p53 (in MCF-7 cells) or the mutant p53 (in MDA cells). Evidence that exonuclease function detected in cytoplasmic extracts is attributed to the p53 is supported by several facts: First, this activity closely parallels with levels and status of endogenous cytoplasmic p53. Second, immunoprecipitation of p53 from cytoplasmic extracts of LCC2 cells markedly reduced the exonuclease activity. Third, the observed 3'-->5' exonuclease in cytoplasmic fraction of LCC2 cells displays identical biochemical properties characteristic of recombinant wild-type p53. The biochemical functions include: (a) substrate specificity; exonuclease hydrolyzes single-stranded DNA in preference to double-stranded DNA and RNA/DNA template-primers, (b) efficient excision of 3'-terminal mispairs from DNA/DNA and RNA/DNA substrates, (c) the preferential excision of purine-purine mispairs over purine-pyrimidine mispairs and (d) functional interaction with exonuclease-deficient DNA polymerase, for example, murine leukemia virus reverse transcriptase (representing a relatively low fidelity enzyme), thus enhancing the fidelity of DNA synthesis by excision of mismatched nucleotides from the nascent DNA strand. Taken together, the data demonstrate that wild-type p53 in cytoplasm, in its noninduced state, is functional; it displays intrinsic 3'-->5' exonuclease activity. The possible role of p53-associated 3'-->5' exonuclease activity in DNA repair in nucleus and cytoplasm is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527892     DOI: 10.1038/sj.onc.1206111

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Exonucleolytic degradation of RNA by p53 protein in cytoplasm.

Authors:  Mary Bakhanashvili; Rachel Gedelovich; Shai Grinberg; Galia Rahav
Journal:  J Mol Med (Berl)       Date:  2007-08-15       Impact factor: 4.599

2.  Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolars.

Authors:  Francine M Benes; Benjamin Lim; Sivan Subburaju
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

3.  Excision of nucleoside analogs from DNA by p53 protein, a potential cellular mechanism of resistance to inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Mary Bakhanashvili; Elena Novitsky; Ethan Rubinstein; Itzchak Levy; Galia Rahav
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  p53 promotes the fidelity of DNA end-joining activity by, in part, enhancing the expression of heterogeneous nuclear ribonucleoprotein G.

Authors:  Ki-Hyuk Shin; Reuben H Kim; Mo K Kang; Roy H Kim; Steve G Kim; Philip K Lim; Ji Min Yochim; Marcel A Baluda; No-Hee Park
Journal:  DNA Repair (Amst)       Date:  2007-03-26

Review 5.  DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders.

Authors:  Vincent E Provasek; Joy Mitra; Vikas H Malojirao; Muralidhar L Hegde
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

6.  Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 protein.

Authors:  Jinwoo Ahn; Masha V Poyurovsky; Nicole Baptiste; Rachel Beckerman; Christine Cain; Melissa Mattia; Kristine McKinney; Jianmin Zhou; Andrew Zupnick; Vanesa Gottifredi; Carol Prives
Journal:  Cell Cycle       Date:  2009-05-15       Impact factor: 4.534

7.  Novel protein-protein interactions of TPPII, p53, and SIRT7.

Authors:  Jarmila Nahálková
Journal:  Mol Cell Biochem       Date:  2015-07-14       Impact factor: 3.396

Review 8.  Principal Aspects Regarding the Maintenance of Mammalian Mitochondrial Genome Integrity.

Authors:  Panagiotis V S Vasileiou; Iordanis Mourouzis; Constantinos Pantos
Journal:  Int J Mol Sci       Date:  2017-08-22       Impact factor: 5.923

9.  Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53.

Authors:  Tuck Seng Wong; Sridharan Rajagopalan; Fiona M Townsley; Stefan M Freund; Miriana Petrovich; David Loakes; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2008-12-09       Impact factor: 16.971

Review 10.  How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor.

Authors:  Teresa Ho; Ban Xiong Tan; David Lane
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.